PARNAXLAB127.95

Parnax Lab Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLMAKERSLNOVARTINDSGRLSHUKRAPHARSUNLOC
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation0.10.10.1
+ Finance Costs0.20.10.0
Changes in Working Capital
+ Inventories0.2-0.30.1
+ Trade Receivables — Current0.80.5-0.3
+ Trade Payables — Current-0.70.30.6
Cash from Operating Activities
Profit Before Tax (per I/S)1.62.41.9
Cash from Operations (pre-tax)-0.30.10.3
+ Income Taxes Paid0.00.00.0
Cash from Operating Activities-0.30.10.3
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)0.10.10.0
+ Disp of Fixed Assets0.20.1
Cash from Investing Activities0.10.3-0.2
Cash from Financing Activities
+ Proceeds from Borrowings1.00.20.0
Cash from Financing Activities-2.9-1.2-0.0
Net Changes in Cash-3.1-0.80.1
Closing Cash1.30.40.5
Reference Items
EBITDA1.62.11.2
EBITDA Margin %21.0528.3717.61
Free Cash Flow (CFO − Capex)-0.3-0.00.3
Cash Paid for Taxes0.00.00.0
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.